Treatment of chronic myelogenous leukemia

Overview of attention for article published in American Journal of Health-System Pharmacy, February 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 9 X users

Readers on

mendeley: 31 Mendeley

So far, Altmetric has seen 11 X posts from 9 X users, with an upper bound of 58,159 followers.

RT @Magil2006: En España Bosutinib y ponatinib, como q chungo chungo...(no financiado) @begosanjoseruiz @Olguitxi https://t.co/ZMKutXbTvY

En España Bosutinib y ponatinib, como q chungo chungo...(no financiado) @begosanjoseruiz @Olguitxi https://t.co/ZMKutXbTvY

RT @sgoncos: Review. Treatment of chronic myelogenous leukemia #ASHP https://t.co/JjSkZf0lz0

Review. Treatment of chronic myelogenous leukemia #ASHP https://t.co/JjSkZf0lz0

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.